Valeant Providing Reporters With an Earnings Metric the SEC Ordered it to Stop Using Post author:Sam Post published:November 9, 2017 Post category:BioPharma Valeant is not the only company to recently push reporters to defy the SEC’s orders. Source: BioSpace You Might Also Like Acelity Launches PREVENA DUO Incision Management System Platform —The First Single-Use Negative Pressure Wound Therapy (NPWT) System For The Simultaneous Management Of Two Incisions May 23, 2017 Prolacta Bioscience To Present At The 2017 Conference On February 22, 2017 February 21, 2017 7 Key Products That Could Help Dig Valeant Out of Its Hole January 9, 2018
Acelity Launches PREVENA DUO Incision Management System Platform —The First Single-Use Negative Pressure Wound Therapy (NPWT) System For The Simultaneous Management Of Two Incisions May 23, 2017
